SYN-TECH Chemical & Pharmaceutical Co. Ltd. (1777) Stock Statistics & Valuation Metrics

SYN-TECH Chemical & Pharmaceutical Co. Ltd. has a market cap or net worth of TWD 3.34B. The enterprise value is TWD 2.32B.

Market Cap

TWD 3.34B

Enterprise Value

TWD 2.32B

SYN-TECH Chemical & Pharmaceutical Co. Ltd. has 44,591,713 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

44,591,713

Owned by Insiders

―

Owned by Institutions

0.09%

SYN-TECH Chemical & Pharmaceutical Co. Ltd.’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 8.85%.

Return on Equity (ROE)

0.10

Return on Assets (ROA)

0.09

Return on Invested Capital (ROIC)

8.85%

Return on Capital Employed (ROCE)

0.12

Revenue Per Employee

5.83M

Profits Per Employee

1.17M

Employee Count

223

Asset Turnover

0.44

Inventory Turnover

2.51

The current PE Ratio of SYN-TECH Chemical & Pharmaceutical Co. Ltd. is 9.97. SYN-TECH Chemical & Pharmaceutical Co. Ltd.’s PEG ratio is 0.93.

PE Ratio

9.97

PS Ratio

2.60

PB Ratio

1.28

Price to FCF

9.59

Price to Operating Cash Flow

8.25

PEG Ratio

0.93

In the last 12 months, SYN-TECH Chemical & Pharmaceutical Co. Ltd. had revenue of 1.30B and earned 261.61M in profits. Earnings per share was 5.87.

Revenue

1.30B

Gross Profit

444.11M

Operating Income

319.86M

Pretax Income

333.92M

Net Income

261.61M

EBITDA

467.00M

Earnings Per Share (EPS)

5.87

In the last 12 months, operating cash flow was 401.22M and capital expenditures -56.32M, giving a free cash flow of 344.90M billion.

Operating Cash Flow

401.22M

Free Cash Flow

344.90M

Free Cash Flow per Share

7.73

SYN-TECH Chemical & Pharmaceutical Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of 5.35%

Dividend Per Share

―

Dividend Yield

5.35%

Payout Ratio

N/A

Free Cash Flow Yield

10.34%

Earnings Yield

9.94%

Beta

0.23

52-Week Price Change

-4.23%

50-Day Moving Average

75.16

200-Day Moving Average

70.68

Relative Strength Index (RSI)

50.46

Average Volume (3m)

52.09K

SYN-TECH Chemical & Pharmaceutical Co. Ltd. upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 06, 2026

Next Earnings Date

Nov 11, 2026

Ex-Dividend Date

―

SYN-TECH Chemical & Pharmaceutical Co. Ltd. as a current ratio of 5.03, with Debt / Equity ratio of 8.77%

Current Ratio

5.03

Quick Ratio

3.91

Debt to Market Cap

0.05

Net Debt to EBITDA

-1.76

Interest Coverage Ratio

318.90

In the past 12 months, SYN-TECH Chemical & Pharmaceutical Co. Ltd. has paid 72.31M in taxes.

Income Tax

72.31M

Effective Tax Rate

0.22

SYN-TECH Chemical & Pharmaceutical Co. Ltd. EV to EBITDA ratio is 4.74, with an EV/FCF ratio of 7.18.

EV to Sales

1.95

EV to EBITDA

4.74

EV to Free Cash Flow

7.18

EV to Operating Cash Flow

6.17

SYN-TECH Chemical & Pharmaceutical Co. Ltd. has TWD 1.11B in cash and marketable securities with TWD 254.95M in debt, giving a net cash position of TWD 858.11M billion.

Cash & Marketable Securities

TWD 1.11B

Total Debt

TWD 254.95M

Net Cash

TWD 858.11M

Net Cash Per Share

TWD 19.24

Tangible Book Value Per Share

TWD 57.79

Gross margin is 38.38%, with operating margin of 28.18%, and net profit margin of 26.07%.

Gross Margin

38.38%

Operating Margin

28.18%

Pretax Margin

32.86%

Net Profit Margin

26.07%

EBITDA Margin

41.14%

EBIT Margin

29.62%

The average price target for SYN-TECH Chemical & Pharmaceutical Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-1.07%

EPS Growth Forecast

10.62%